-
of the Genomics Research Centre . Soskic Group studies molecular mechanisms that regulate B cell activation, antibody production and their genetic variability. We use a wide range of immunological and
-
, predict the future course of the disease, and uncover the mechanisms of resistance to treatment. We leverage spatial and longitudinal data from patients and patient-derived model systems, evolutionary
-
: The Harschnitz Group studies the molecular and cellular mechanisms that underlie susceptibility to viral and autoimmune disease of the human nervous system. Its interests range from developmental neurobiology
-
computational approaches. The aim is to uncover mechanisms driving therapeutic resistance, tumour reshaping, and hematopoietic impact under CAR T-cell pressure, with implications for improving immunotherapy
-
assembloids, xenografts and bioengineered models, to uncover actionable mechanisms and advance them towards translational applications. About the lab: We focus on the dynamics of brain disorders, with a strong